| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |